1. Fahn S. Concept and classification of dystonia. Adv Neurol. 1988; 50:1–8. PMID:
3041755.
2. Alarcon F, Zijlmans JC, Duenas G, Cevallos N. Poststroke movement disorders: report of 56 patients. J Neurol Neurosurg Psychiatry. 2004; 75:1568–1574. PMID:
15489389.
Article
3. Jankovic J. Treatment of cervical dystonia with botulinum toxin. Mov Disord. 2004; 19(Suppl 8):S109–S115. PMID:
15027062.
Article
4. Nijmeijer SW, Koelman JH, Kamphuis DJ, Tijssen MA. Muscle selection for treatment of cervical dystonia with botulinum toxin: a systematic review. Parkinsonism Relat Disord. 2012; 18:731–736. PMID:
22575237.
5. Esquenazi A, Cioni M, Mayer NH. Assessment of muscle overactivity and spasticity with dynamic polyelectromyography and motion analysis. Open Rehabil J. 2010; 3:143–148.
Article
6. Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T. The prevalence of primary dystonia: a systematic review and meta-analysis. Mov Disord. 2012; 27:1789–1796. PMID:
23114997.
Article
7. Takeuchi N, Chuma T, Mano Y. Phenol block for cervical dystonia: effects and side effects. Arch Phys Med Rehabil. 2004; 85:1117–1120. PMID:
15241760.
Article
8. Jankovic J. Medical treatment of dystonia. Mov Disord. 2013; 28:1001–1012. PMID:
23893456.
Article
9. Peng Q, Park HS, Shah P, Wilson N, Ren Y, Wu YN, et al. Quantitative evaluations of ankle spasticity and stiffness in neurological disorders using manual spasticity evaluator. J Rehabil Res Dev. 2011; 48:473–481. PMID:
21674395.
Article
10. Comella CL, Buchman AS, Tanner CM, Brown-Toms NC, Goetz CG. Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance. Neurology. 1992; 42:878–882. PMID:
1565246.
Article